{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fstartup-insider.simplecast.com%2Fepisodes%2Fspotlight-YwIHkcQv-RKIbuBJ_","width":444,"version":"1.0","type":"rich","title":"5 Milliarden Dollar Exit: die Reise vom Seed bis zum Unicorn – Dr. Dominik Schumacher (Tubulis) & Dr. Frank Hensel (HTGF)","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/97a167f4-fd47-43be-a3f7-e056c5f93dd5/5321d181-48fa-4be0-8b69-025cad953be0/frankhensel_dominik_schuhmacher_htgf_tubulis3.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2d2f7bc8-c1a9-4137-ac9e-40ae9f90ed38\" height=\"200\" width=\"100%\" title=\"5 Milliarden Dollar Exit: die Reise vom Seed bis zum Unicorn – Dr. Dominik Schumacher (Tubulis) &amp; Dr. Frank Hensel (HTGF)\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Tubulis wird für bis zu 5 Mrd. USD von Gilead Sciences übernommen – der größte Exit in der HTGF-Geschichte. CEO Dominik Schumacher und Investor Frank Hensel über die Reise vom Seed bis zum Unicorn.\n"}